EMP2 is a novel therapeutic target for endometrial cancer stem cells

por Kiyohara, Meagan H., Dillard, Christen, Tsui, Jessica, Kim, Sara Ruth, Lu, Jianyi, Sachdev, Divya, Goodglick, Lee, Tong, Maomeng, Torous, Vanda Farahmand, Aryasomayajula, Chinmayi, Wang, Wei, Najafzadeh, Parisa, Gordon, Lynn K., Braun, Jonathan, McDermott, Sean, Wicha, Max S., Wadehra, Madhuri
Publicado 2017

GATA3 expression in clear cell adenocarcinoma of the lower urinary tract: a potential diagnostic pitfall

por Akgul, Mahmut, Humble, Robert, Osme, Abdullah, Yuce, Servet, Kocak, Elif N., Najafzadeh, Parisa, Sangoi, Ankur, Pattnaik, Niharika, Mishra, Sourav, Sharma, Shivani, Shaker, Nada, Kaushal, Seema, Baisakh, Manas, Lightle, Andrea R., Balzer, Bonnie L., Xiao, Guang-Qian, MacLennan, Gregory T., Osunkoya, Adeboye O., Parwani, Anil, Cheng, Liang, Bellizzi, Andrew, Mohanty, Sambit K.
Publicado 2022